Cigna (CI) Stock Forecast & Price Target

Compare

3,504 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CI Analyst Ratings

Strong Buy

13 Buy

2 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$334.47

▲(21.14% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $334.47 with a high forecast of $378.00 and a low forecast of $294.00. The average price target represents a 21.14% change from the last price of $276.11.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"242":"$242","379":"$379","276.25":"$276.3","310.5":"$310.5","344.75":"$344.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":378,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$378.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":334.47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$334.47</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":294,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$294.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[242,276.25,310.5,344.75,379],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,272.04,280.19076923076926,288.3415384615385,296.4923076923077,304.64307692307693,312.7938461538462,320.9446153846154,329.09538461538466,337.24615384615385,345.3969230769231,353.54769230769233,361.6984615384615,369.84923076923076,{"y":378,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,272.04,276.8423076923077,281.6446153846154,286.4469230769231,291.2492307692308,296.0515384615385,300.8538461538462,305.65615384615387,310.45846153846156,315.26076923076926,320.06307692307695,324.86538461538464,329.66769230769233,{"y":334.47,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,272.04,273.7292307692308,275.41846153846154,277.10769230769233,278.79692307692306,280.48615384615385,282.17538461538464,283.8646153846154,285.55384615384617,287.24307692307696,288.9323076923077,290.6215384615385,292.3107692307692,{"y":294,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":328.89,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":270.58,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":288.28,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":302.63,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":325.93,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.85,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":259.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.54,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.04,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":272.04,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$378.00

Average Price Target$334.47

Lowest Price Target$294.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Kevin Fischbeck

Bank of America Securities

$269.6→$378

Buy

36.90%

Upside

Reiterated

12/10/25

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI) and Harmony Biosciences Holdings (NASDAQ: HRMY)

Charles Rhyee

TD Cowen

$333

Buy

20.60%

Upside

Reiterated

12/05/25

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Neurocrine (NASDAQ: NBIX) and Roche Holding AG (Other OTC: RHHVF)

Jason Cassorla

Guggenheim

$309→$318

Buy

15.17%

Upside

Reiterated

12/02/25

Cigna price target raised to $318 from $309 at GuggenheimCigna price target raised to $318 from $309 at Guggenheim

Lance Wilkes

Bernstein

$346→$294

Hold

6.48%

Upside

Reiterated

11/12/25

Cigna price target lowered to $294 from $346 at BernsteinCigna price target lowered to $294 from $346 at Bernstein

Scott Fidel

Goldman Sachs

$370→$330

Buy

19.52%

Upside

Reiterated

11/04/25

Cigna price target lowered to $330 from $370 at Goldman SachsCigna price target lowered to $330 from $370 at Goldman Sachs

Lisa Gill

J.P. Morgan

$428→$375

Buy

35.82%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Cigna (NYSE: CI)

Stephen Baxter

Wells Fargo

$354→$300

Hold

8.65%

Upside

Reiterated

11/04/25

Cigna (CI) Gets a Hold from Wells FargoWe rate CI Equal Weight.

John Ransom

Raymond James

$385→$350

Buy

26.76%

Upside

Reiterated

11/03/25

Cigna price target lowered to $350 from $385 at Raymond JamesCigna price target lowered to $350 from $385 at Raymond James

Andrew Mok CFA

Barclays

$383→$300

Buy

8.65%

Upside

Reiterated

11/03/25

Cigna (CI) Receives a Buy from Barclays

Erin Wright

Morgan Stanley

$390→$355

Buy

28.57%

Upside

Reiterated

10/31/25

Morgan Stanley Reaffirms Their Buy Rating on Cigna (CI)

David S Macdonald

Truist Financial

$375→$310

Buy

12.27%

Upside

Reiterated

10/31/25

Cigna (CI) Receives a Buy from Truist Financial

Michael Wiederhorn

Oppenheimer

$365

Buy

32.19%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from Oppenheimer

A.J. Rice

UBS

$340

Buy

23.14%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from UBS

Ben Hendrix

RBC Capital

$371→$344

Buy

24.59%

Upside

Reiterated

10/31/25

RBC Capital Sticks to Its Buy Rating for Cigna (CI)

Justin Lake

Wolfe Research

$345→$325

Buy

17.71%

Upside

Reiterated

10/15/25

Wolfe Research Reaffirms Their Buy Rating on Cigna (CI)Wolfe Research analyst Justin Lake lowered the price target on CIGNA (NYSE: CI) to $325.00 (from $345.00) while maintaining a Outperform rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Kevin Fischbeck

Bank of America Securities

$269.6→$378

Buy

36.90%

Upside

Reiterated

12/10/25

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI) and Harmony Biosciences Holdings (NASDAQ: HRMY)

Charles Rhyee

TD Cowen

$333

Buy

20.60%

Upside

Reiterated

12/05/25

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Neurocrine (NASDAQ: NBIX) and Roche Holding AG (Other OTC: RHHVF)

Jason Cassorla

Guggenheim

$309→$318

Buy

15.17%

Upside

Reiterated

12/02/25

Cigna price target raised to $318 from $309 at GuggenheimCigna price target raised to $318 from $309 at Guggenheim

Lance Wilkes

Bernstein

$346→$294

Hold

6.48%

Upside

Reiterated

11/12/25

Cigna price target lowered to $294 from $346 at BernsteinCigna price target lowered to $294 from $346 at Bernstein

Scott Fidel

Goldman Sachs

$370→$330

Buy

19.52%

Upside

Reiterated

11/04/25

Cigna price target lowered to $330 from $370 at Goldman SachsCigna price target lowered to $330 from $370 at Goldman Sachs

Lisa Gill

J.P. Morgan

$428→$375

Buy

35.82%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Cigna (NYSE: CI)

Stephen Baxter

Wells Fargo

$354→$300

Hold

8.65%

Upside

Reiterated

11/04/25

Cigna (CI) Gets a Hold from Wells FargoWe rate CI Equal Weight.

John Ransom

Raymond James

$385→$350

Buy

26.76%

Upside

Reiterated

11/03/25

Cigna price target lowered to $350 from $385 at Raymond JamesCigna price target lowered to $350 from $385 at Raymond James

Andrew Mok CFA

Barclays

$383→$300

Buy

8.65%

Upside

Reiterated

11/03/25

Cigna (CI) Receives a Buy from Barclays

Erin Wright

Morgan Stanley

$390→$355

Buy

28.57%

Upside

Reiterated

10/31/25

Morgan Stanley Reaffirms Their Buy Rating on Cigna (CI)

David S Macdonald

Truist Financial

$375→$310

Buy

12.27%

Upside

Reiterated

10/31/25

Cigna (CI) Receives a Buy from Truist Financial

Michael Wiederhorn

Oppenheimer

$365

Buy

32.19%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from Oppenheimer

A.J. Rice

UBS

$340

Buy

23.14%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from UBS

Ben Hendrix

RBC Capital

$371→$344

Buy

24.59%

Upside

Reiterated

10/31/25

RBC Capital Sticks to Its Buy Rating for Cigna (CI)

Justin Lake

Wolfe Research

$345→$325

Buy

17.71%

Upside

Reiterated

10/15/25

Wolfe Research Reaffirms Their Buy Rating on Cigna (CI)Wolfe Research analyst Justin Lake lowered the price target on CIGNA (NYSE: CI) to $325.00 (from $345.00) while maintaining a Outperform rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

1 Month

xxx

Success Rate

17/23 ratings generated profit

Average Return

+1.57%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 73.91% of your transactions generating a profit, with an average return of +1.57% per trade.

3 Months

xxx

Success Rate

19/29 ratings generated profit

Average Return

+4.69%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.52% of your transactions generating a profit, with an average return of +4.69% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

21/28 ratings generated profit

Average Return

+18.07%

reiterated a buy rating last month

Copying Scott Fidel's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +18.07% per trade.

2 Years

xxx

Success Rate

17/19 ratings generated profit

Average Return

+24.25%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 89.47% of your transactions generating a profit, with an average return of +24.25% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CI has received 27 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 334.47.

Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

Next quarter’s earnings estimate for CI is $7.87 with a range of $7.67 to $8.00. The previous quarter’s EPS was $7.83. CI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Sales Forecast

Next quarter’s sales forecast for CI is $70.14B with a range of $67.07B to $71.37B. The previous quarter’s sales results were $69.77B. CI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Stock Forecast FAQ

What is CI’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 334.47.

What is CI’s upside potential, based on the analysts’ average price target?

Cigna Corp has 21.14% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CI a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Strong Buy which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.

What is Cigna Corp’s price target?

The average price target for Cigna Corp is 334.47. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $378.00 ,the lowest forecast is $294.00. The average price target represents 21.14% Increase from the current price of $276.11.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of CI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cigna (CI) Stock Forecast & Price Target

CI Analyst Ratings

CI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

CI Analyst Recommendation Trends

CI Financial Forecast

CI Earnings Forecast

CI Sales Forecast

CI Stock Forecast FAQ

Detailed List of Analyst Forecasts